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Summal-y 
A variant of severe combined lmmunodeficiency syndrome (SCID) with a selective inability to 
produce CD8 single positive T  cells and a signal transduction defect in peripheral CD4 + cells 
has recently been shown to be the  result of mutations in the  ZAP-70  gene.  T  cell receptor 
(TCR) signaling requires the association of the ZAP-70 protein tyrosine kinase with the TCR 
complex. Human T  cell leukemia virus type I-transformed CD4 + T  cell lines w.ere established 
from ZAP-70-deficient patients and normal controls. ZAP-70 was expressed and appropriately 
phosphorylated in normal T  cell lines after TCR  engagement, but was not detected in T  cell 
lines from ZAP-70-deficient patients. To determine whether signaling could be reconstituted, 
wild-type ZAP-70 was introduced into deficient cells with a ZAP-70 retroviral vector. High 
titer producer  clones  expressing ZAP-70  were  generated in  the  Gibbon ape leukemia virus 
packaging line PG13.  After transduction,  ZAP-70 was detected  at levels equivalent to those 
observed in normal cells,  and was appropriately phosphorylated on tyrosine after receptor en- 
gagement. The kinase activity of ZAP-70 in the reconstituted cells was also appropriately upregu- 
lated by receptor aggregation. Moreover, normal and transduced cells, but not ZAP-70-deficient 
cells, were able to mobilize calcium after receptor ligation, indicating that proximal TCR sig- 
naling was reconstituted.  These results indicate that this form of SClD  may be corrected by 
gene therapy. 
S 
CID  is  a  heterogeneous  group  of  genetic  disorders 
characterized  by  an  absence  of T  and  B  lymphocyte 
function. Recently, one form of autosomal recessive SClD 
has  been  shown  to  be  caused  by defects  in  the  ZAP-70 
protein  tyrosine  kinase  (PTK;  1-3).  The  phenotype  of 
ZAP-70-deficient  SClD  is  distinctive  with an  absence  of 
peripheral CD8 + T  cells  and normal to high levels of pe- 
ripheral CD4 + T  cells that cannot signal through the TCR. 
ZAP-70 has a relative molecular mass of 70-kD, and is ex- 
pressed exclusively in thymocytes, T  cells, and NK cells (4). 
It contains two tandemly arranged Src homology 2  (SH2) 
domains and a carboxy-terminal kanase domain (5). 
Engagement of the  TCR  normally results in  activation 
of intracellular signal transduction pathways culminating in 
gene  expression  and  cellular proliferanon  (6).  Much  evi- 
dence  indicates  that  initiation  of the  signal  is  mediated 
through phosphorylation of two tyrosines located within a 
17-amino acid motif that is present in all conserved chains 
of the TCR, termed the immunoreceptor tyrosine activa- 
tion motif (ITAM, 7-9). The Src family PTKs Lck and Fyn 
have been shown  to  play important  roles in  the  tyrosine 
phosphorylation  of  these  ITAMs  (10-12).  ZAP-70  can 
then  associate  with  the  phosphorylated  ITAMs  of  the 
CD3-~  and  CD3-~  chains  of the  TCR  through  its  SH2 
domains (5,  13,  14).  ZAP-70 is itself phosphorylated upon 
this interaction, in a process that is dependent on Src family 
PTKs (5,  14-16). The subsequent steps in the TCR signal- 
ing pathway that result in T  cell proliferation and cytokine 
release are not well defined. However, the observation that 
there  is  an  almost  complete  abrogation  of TCR  signal 
transduction  in  CD4 +  cells  in  ZAP-70-deficient  patients 
(1-3) indicates a critical role for ZAP-70 in this process. 
Interestingly, there is a second member of this PTK fam- 
ily, termed Syk, that is structurally homologous to ZAP-70 
and shares 57% sequence identity (5,  17).  Syk is expressed 
in a wide variety of cells including B cells, mast cells, gran- 
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eral T  cells is significantly lower  (<10%  of the level in B 
cells; 4). Additionally, although Syk is known to be impor- 
tant for signaling in B  cells, mast cells, and granulocytes, its 
role in T  cell signaling is not  clear (18-25).  We  have  re- 
cently shown that high levels of endogenous Syk may par- 
tially compensate for the absence of ZAP-70 in thymocytes 
from  a  ZAP-70-deficient  patient,  resulting  in  signaling 
through the TC1L (26).  In contrast with thymocyte signal- 
ing, however, there is a lack of signaling, as assessed by pro- 
tein tyrosine phosphorylation and mobilization of [Ca2+],, 
in the peripheral CD4 + T  cells from this patient (26).  This 
observation again underscores  the  importance  of ZAP-70 
in the signal transduction pathway in peripheral T  cells. 
In the present work, we demonstrate successful reconstitu- 
tion of TCR-mediated signaling in a CD4 + peripheral T  cell 
line from this ZAP-70-deficient patient. The cell lines have 
previously been shown to have defective TCP,.-mediated sig- 
naling analogous to that seen in primary cells from the patient 
(26).  Cells were reconstituted by retroviral-mediated trans- 
duction with the wild-type ZAPo70 gene.  After transdnc- 
tion of the patient's cell line, TCR  signaling was normalized 
as measured by ZAP-70 phosphorylation, ZAP-70 in vitro 
kinase activity, and reconstitution of calcium mobilization. 
Materials  and Methods 
Cell Lines.  The patient with ZAP-70 deficiency has been re- 
ported previously (26). Briefly, HTLV-I transformation  ofpenpheral 
blood T cells from normal adult donors and the ZAP-70-deficient 
patient (AB) were performed as described (27). The normal and AB 
HTLV-I hnes were maintained in RPMI 1640 with 10% FCS, IL-2 
(20 U/ml; gift from Carolyn Paradise, Chiron Corp., Emeryville, 
CA), 2 mM 1-glutamine, 50 U/ml penicillin, and 50 Ixg/ml strep- 
tomycin. The phenotype of control and ZAP-70-deficlent T cell 
lines was similar; each expressed TCR.-oL/I3 as well as CD4. Addi- 
tionally, all cell hnes were IL-2 dependent. The human T leukemia 
cell hne Jurkat was maintained in RPMI 1640 with 10% FCS. 
Construction  of the  G1ZAPSvNa  Vector and  Packaqing Line. 
The  normal  ZAP-70  cDNA  (5)  was  excised  fi-om  Bluescript 
KS(+)  as an EcolLl fragment, blunted with Klenow DNA poly- 
merase, and cloned into the SnaBI site of the pG1XSvNa vector 
plasrmd, a Moloney munne leukemia virus-based retroviral vec- 
tor (28; Genetic Therapy, Inc., Gaithersburg, MD). 
To generate a high tlter packaging line, the resultant pGZAPS- 
vNa plasrmd was transfected into the gp+env 86 ecotropic pack- 
aging hne using DOTAP reagent (Boehnnger Mannheim, India- 
napohs IN) (29). Supematants from the ecotroplc line were then 
used to infect PG13 amphotroplc packaging cells (30), and a sin- 
gle clone with a nter of 4 ×  105/ml was used for transductions. 
Retroviral Transductions.  pG1ZAP70SvNa  supernatants  were 
added at a  1:1  dilution to AB cells in logarithmic growth phase 
(105 cells/ml) in the presence of IL-2 (20  U/ml)  and 3  ~g/ml 
protamine. Fresh viral supernatants were added every 24 h for 3 
successive days.  The  AB  cells  were  then  &luted to "-'5  ×  104 
celts/ml, and 1-ml ahquots were seeded into the wells of a 24- 
well plate and selected m 400  p~g/ml of G418 (geneticin;  GIBCO- 
BRL, Galthersburg,  MD). In three different transductions,  approxi- 
mately four to eight wells from each plate grew after 3-6 weeks of 
G418 selection. Control cells were transduced with the LN vector, 
which contains only the neomycin phosphotransferase gene (28). 
Immunoprecipitations and Kinase Assays.  Cells were starved over- 
mght in RPMI 1640 with 1% FCS (in the absence of IL-2). After 
washing twice in HBSS, cells were resuspended at 2  ×  107 cells/ 
nil, incubated with  100  ~1 of a biotinylated ann-CD3  antibody 
(Leu4 mAb; Becton Dickinson & Co., Mountain View, CA) for 
15  min on ice, and then cross-linked with streptavidan (30  p,g/ 
ml, Calblochem/Novabiochem Corp., La Jolla, CA) for 2 rain at 
37°C. Cells were lysed in an NP-40 lysxs buffer (31), and postnu- 
clear supernatants were lmmunoprecapltated with a rabbit poly- 
clonal antibody to ZAP-70,  1222  (5), followed by collectmn on 
protein  A/G  agarose  (Santa  Cruz  Blotechnology  Inc.,  Santa 
Cruz,  CA).  Immunoprecipitates were  separated on  7.5%  SDS- 
PAGE gels and transferred electrophoretically to Hybond mem- 
branes (Amersham, Arlington Hmghts, IL). 
Membranes were blotted with a mixture of the 4G10 (Upstate 
Baotechnology Inc., Lake Placid, NY) and pY72 antiphosphoty- 
rosine mAbs (gift from Bart Sefton, Silk Institute, La Jolla, CA) as 
previously described (31).  Blots probed with a ZAP-70-specific 
mAb, 2F3.2 (14), were blocked in TBS (150 mM NaC1,  20 mM 
Tris, pH 7.5) containing 5% BSA and 0.1% Tween 20. Immuno- 
complexes were  visualized using  the  enhanced  chemilumines- 
cence detection system (Amersham). 
In vitro kinase assays were performed essentially as reported 
(32). Immunoprecipitates were washed an lysis buffer followed by 
150 mM NaC1 and 50 mM Tras HC1,  pH 7.5. Precipitates were 
then incubated m 25  bd kinase buffer (20 mM Pipes, pH 7.0,  10 
mM MnCI> and 5 p,  Ci [',/32p]ATP [3,000  Ci/mM]) for 10 man 
at  30°C,  washed  once,  eluted  by  bolhng  in  2×  SDS  sample 
buffer, resolved on SDS-PAGE, and wsualized by autoradiography. 
Aleasurement of Cytoplasmic Calcium Concentration.  T  cell  lines 
were starved overnight in 1LPMI  1640 with 10% FCS (in the ab- 
sence of IL-2), and were loaded with Indo-1  (Molecular Probes, 
Inc., Eugene, OIL) in the same medium at 20°C for 45 min. Cells 
were washed and resuspended at "°10~' cells/nil in HBSS contain- 
ing 1% BSA. Cells were stimulated with bmtinylated anti-Leu4 
mAb  followed by  streptavidin at  37°C  111  a  constantly stirred 
acrylic cuvette. Fluorescence measurements to determine [Ca2+], 
were performed with a spectrofluorimeter (Photon Technologws, 
South Brunswick,  NJ) at an excitation wavelength of 350 nm (4-urn 
bandwidth), and with dual simultaneous momtoring of emission 
at 405  and 485  nm (10-nm bandwidth). The rano of emission at 
405/485  nm was measured at a rate of 2 Hz and is presented as a 
function of time (s). 
Results 
Lack of ZAP-70 Expression in a Peripheral  CD4 + Cell Line 
Derived from Patient AB.  We have previously shown that pa- 
tient AB, the product of a consanguineous union, has ZAP- 
70-deficient SCID (26). This syndrome was diagnosed from 
the patient's peripheral blood T  cell phenotype  (adequate 
CD4 + count with a marked paucity ofCD8 + T  cells), the fail- 
ure of his PBMCs to mediate increases in [Ca2+], and an ab- 
sence of detectable ZAP-70 protein. Additionally, no ZAP- 
70-specific tLNA  could  be  detected  in  thymocytes  from 
panent AB. To study signaling in peripheral CD4 + cells from 
this patient, an HTLV-I-transformed polyclonal T  cell line 
was derived. HTLV-I-transformed CD4 + T  cell lines from 
normal individuals were used as controls. Like CD4 + HTLV-I 
lines derived from normal individuals, the patient's HTLV-I 
T  cell line expressed CD4, the Lck and Fyn Src family PTKs, 
the TC1L-~ chain, and PLC-yl (data not shown). All HTLV-I 
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Figure 1.  Map of the G1ZAPSvNa vector. Shown are posmons of the 
5' long terminal repeat (5' LTP,), ZAP-70 cDNA, SV-40 promoter/en- 
hancer, neomycin phosphotransferase  (ne0) gene, and 3' long tertmnal re- 
peat (3' LTR). 
lines required the presence of exogenous IL-2 (20 U/nil) in 
the culture medium to sustain growth.  In contrast with con- 
trol HTLV-I lines (Normal), however, ZAP-70 expression was 
not detected in the AB HTLV-I line (AB; see Fig. 2 B). These 
data indicated that the AB HTLV-I line could be used as a 
tool to  assess whether the transduction of wild-type ZAP-70 
would result in the reconstitution of TCR-mediated signaling. 
ZAP-70  Is  Expressed  and  Tyrosine  Phosphorylated  after 
Transduction  with GIZAPSvNa.  To  determine  whether 
wild-type ZAP-70 would restore TCP,. function m AB T  cells, 
ceils were transduced with a retroviral vector G1ZAPSvNa, 
into which the entire ZAP-70 cDNA was cloned (Fig.  1). 
Pools of AB cells from  three different transduction experi- 
ments  were  selected in  G418  for  3-6  wk  to  obtain  cells 
containing GIZAPSvNa (AB/ZAP-70 cells). In these trans- 
duced T  cell pools, ZAP-70 was expressed at levels ranging 
from 0.2 to 2.0-fold of the levels observed in control T  cell 
lines (data not shown).  In Fig. 2  B,  ZAP-70 expression in 
an AB/ZAP-70  T  cell pool is equivalent to  that  observed 
in a normal T  cell line (Normal). This indicates that retrovi- 
ral transduction of ZAP-70 into deficient cells can result in 
approximately  normal  levels  of ZAP-70  expression.  The 
level of ZAP-70  expressed in  six individual pools of AB/ 
ZAP-70-transduced cells did not change after up to 8  mo of 
continuous culture in the absence of G418, as monitored by 
immunoblot analysis (data not shown).  This result demon- 
strates that ZAP-70 can be stably expressed in cultured T  cells 
after transduction with the G 1ZAPSvNa retroviral vector. 
Upon  TCR  stimulation,  ZAP-70  normally  associates 
with phosphorylated ITAMs that are present in the CD3-e 
or-{ chains, and is itselfphosphorylated (5,  13-16). There- 
fore, we assessed whether ZAP-70 would be tyrosine phos- 
phorylated in  AB/ZAP-70-reconstituted cells after recep- 
tor  engagement.  Cell  lines  were  rested  overnight  in  the 
absence of exogenous IL-2 before stimulation of the TCR 
with  a  biotlnylated  anti-CD3  mAb  (Leu4)  /bilowed  by 
cross-linking with  streptavidin.  In a  normal as well as the 
reconstituted cell line  (AB/ZAP-70),  the  70-kD  ZAP-70 
protein was  tyrosine phosphorylated upon  TCR  aggrega- 
tion.  It  is  interesting to  note  that  several molecular mass 
species of >70  kD  were  also  tyrosine phosphorylated,  al- 
beit at  lower levels, in  ZAP-70  immunoprecipitates from 
oL-CD3-stimulated normal and reconstituted cell lines. Be- 
cause the phosphotyrosine-reactlve bands in the AB/ZAP- 
70-transduced  cells  were  of slightly lower  intensity  than 
those observed in the normal T  cells, these higher molecu- 
lar  weight  species  were  not  evident  in  the  AB/ZAP-70 
lane shown  In Fig. 2  A.  On longer ECL  exposures,  how- 
ever, the identical pattern of phosphotyrosine-reactive bands 
ZAP-70 IP  Figure 2.  Retrovlral-mechated 
"-  O ~  transductlon  of  the  wild-type 
ZAP-70 gene results m ZAP-70 
~  expression  and  its phosphoryla- 
tion upon CD3 aggregaUon. (A) 
N  ZAP-70  was  lmmunoprecipi- 
tated  using  a  polyclonal  rabbit 
ocCD~ ~= +  ~= +  === +  annbody from a normal PBL line 
It  '~  (Normal),  a  ZAP-70-deficmnt 
91h  PBL line (AB), and a ZAP-70- 
~Q  ~  deficient PBL  line reconstituted 
Q  Q  by retrovlral-me&ated transduc- 
tmn  with  a  wild-type  ZAP-70 
0t  P-Tyr  gene  (AB/ZAP-70).  107  cells 
were either unsnmutated (-) or 
b  stimulated (+) with a bmtmylated 
antl-CD3  mAb  followed  by 
~  ~  streptawdin Immunopreclpitated 
[ysates were  fractlonated  on  a 
polyacrylamlde gel, analyzed by 
o/Z~P-70  immunoblottmg  with  the  4GI0 
monoctonal  annphosphotyrosme 
annbody, and developed with enhanced chemiluminescence to assess  the 
phosphorylanon status of ZAP-70.  (B)  The blot was stopped  and re- 
probed with a ZAP-70-speclfiC *nAb to assess the level of tmmunopre- 
clpitated ZAP-70. 
was also observed in the AB/ZAP-70 ceils (data not shown). 
This  result  was  reproducible  in  six  tested  pools  of AB/ 
ZAP-70-transduced  cells, with  levels  of ZAP-70  ranging 
from  0.2-  to  2.0-fold of those  observed in  control T  cell 
lines.  No  tyrosine-phosphorylated ZAP-70  would be  ex- 
pected, or was observed, in the nontransduced AB ceils or 
in AB cells transduced with the LN vector, since the ZAP- 
70  protein  is not  expressed in  these  cells  (Fig.  2  and  data 
not shown). Thus, one of the proximal events of TCR  sig- 
naling,  the tyrosine phosphorylatlon of ZAP-70 itself, was 
reconstituted in AB/ZAP-70 cells. 
In  Vitro  Kinase  Activity  of ZAP-70  Is  Activated  by  TCR 
Stimulation in AB/ZAP-70  Cells.  To  investigate  whether 
ZAP-70 is activated as a result of CD3 clustering in the re- 
constituted ZAP-70-deficient HTLV-I cell line (AB/ZAP- 
70),  an  in  vitro  klnase  assay  was  performed.  After  CD3 
stlnmlation,  immunoprecipitation with  a  ZAP-70--specific 
antibody  was  performed  in  the  Jurkat  T  cell  leukemia 
clone,  normal and AB  HTLV-I  T  cell lines, as well as in 
two  different  pools  of AB-transduced  ceils  (AB/ZAP-70~ 
and AB/ZAP-70b). Immunoprecipitates were incubated in 
the  presence  of [2/32p]ATP.  ZAP-70  was  autophosphory- 
lated inJurkat T  cells, as well as in the normal and reconsti- 
tuted  AB/ZAP-70  cell lines,  but  not  in  the  AB  cell line 
(Fig. 3). This klnase activity increased upon receptor stimu- 
lation  (Fig.  3).  Within  each  cell line  tested,  the  level  of 
ZAP-70 protein immunoprecipitated before and after CD3 
cross-linking was the same as that assessed by immunoblot- 
ting with an anti-ZAP-70 mAb. The level of ZAP-70 in the 
AB/ZAP-70b pool (equivalent to that in a normal HTLV-I 
T  cell  line),  however,  was  approximately fivefold higher 
than  in the AB/ZAP-70~ pool (data not shown),  account- 
ing for the lower ZAP-70 kinase activity observed in AB/ 
ZAP-70~,  as compared with the  normal and AB/ZAP-70  b 
lines (Fig. 3). Interestingly, a protein with a molecular mass 
of "-'140  kD,  which  coimmunoprecipltated  only  in  the 
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Figure 3.  In vitro kinase  activity  of ZAP-70 as stimulated  by TCR ag- 
gregation in ZAP-70-reconstituted cells.  Jurkat T cells, as well as PBL 
lines from a normal individual (Normal), patient AB, and two different 
pools of ZAP-70-transduced  cells (AB/ZAP-70, and AB-ZAP-70b),  were 
assessed for autophosphorylation.  After TCR aggregation (+), lysates from 
107 cells were immunopreclpltated  with a polyclonal ZAP-70-speclfiC 
antibody, and an in vitro klnase assay was performed The amount of 
ZAP-70 lmmunoprecipltated  before and after stnnulatlon  was identical,  as 
assessed by c~-ZAP-70  lmmunoblottlng (not  shown). 
presence  of ZAP-70, was  also phosphorylated after TC1L 
stimulation. Although the identity of this second protein is 
not known, its phosphorylation also increased upon TCR 
ligation in both normal and reconstituted cell lines (Fig. 3). 
We are presently analyzing whether the  140-kD protein is 
expressed as a consequence of HTLV-I transformation, and 
furthermore,  whether  it  can  be  coimmunoprecipitated 
with antibodies directed against different ZAP-70 epitopes. 
Calcium  Mobilization  after  TCR  Stimulation  Is  Dependent 
on ZAP-70 Expression.  The increases observed in cytoso- 
lic calcium concentrations [Ca2+]1 after TCR aggregation is 
absent in ZAP-70-deficient T  cells (1-3).  Calcium flux is 
one of the proximal events induced upon TCR stimulation 
(10-12, 33-35). We therefore assessed  whether changes in 
[Ca2+].  would be  observed in  reconstituted AB/ZAP-70 
cells.  For calcium measurements, cells were loaded with the 
calcium-sensitive dye Indo-1 and stimulated with a biotin- 
ylated  CD3  mAb  followed  by  streptavidin.  Changes  in 
[Ca2+]1 were then monitored by fluorimetry. In contrast to 
AB cells, in which little or no [Ca2+]1 flux was noted, nor- 
mal cells and three different pools of AB/ZAP-70-recon- 
stituted  cells  (including AB/ZAP-70  a and  AB/ZAP-70b) 
had  a  sustained increase  In  [Ca2+]1 upon  receptor  cross- 
linking (Fig. 4  and data not shown). Equivalent loading of 
all cell lines with Indo-1 was affirmed in all experiments by 
demonstrating calcium flux after addition of calcium iono- 
phore (ionomycin; data not shown). 
Discussion 
We have shown that retroviral-mediated transduction of 
the wild-type ZAP-70 cDNA into a CD4 + HTLV-I-trans- 
formed T  cell line from a ZAP-70-deficient patient results 
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Figure 4.  ZAP-70  is reqmred  for calcium  mobilization  afi:er  TCtL stimula- 
tion. Cells  fi'om  a ZAP-70-deficlent  PBL line (AB), a ZAP-70-reconstltuted 
line (AB/ZAP-7@,  and a normal PBL lane (Normal) were loaded wath 
the calcium-sensitive  dye Indo-1 and analyzed for increases m [Ca2+],. 
Cells were stimulated  wath a baotlnylated  oe-CD3 antibody (Leu4-B) fol- 
lowed by streptavadan (SA), as indicated. Changes  in  [Ca2+]l were moni- 
tored by fluonmetrg as a measure of the ratio of emission  at 405/485 nm 
(ordinate axis) using a Photon Technologies  spectrofluonmeter  for the in- 
dicated time period (s). 
in reconstitution of the proximal TCtL signaling pathway, 
as assessed by the phosphorylation and activation of ZAP-70 
itself and  by  the  mobilization of cytosolic  calcium.  This 
phenotypic correction was  observed in six different pools 
ofT cells transduced with G1ZAPSvNa. Since the level of 
ZAP-70 in each transduced T  cell pool did not vary during 
>8  mo  of culture in the  absence of G418  selection, this 
retroviral-based vector can be used to achieve stable ZAP-70 
expression. Upon similar transduction of G 1ZAPSvNa into 
normal  HTLV-I-transformed  T  cells,  overexpression  of 
ZAP-70 could not be achieved, suggesting that high levels 
of ZAP-70 were  counterselected in cultured T  cells  (data 
not shown). Further analyses in animal models will be nec- 
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sity of the T  cell repertoire is maintained after transduction 
with the G1ZAPSvNa retroviral vector. 
Multiple  cellular PTKs interact with the TCR  and con- 
tribute  to  the  signal  transduction  pathway,  including  the 
Src  family PTKs  Lck and  Fyn,  as well  as the  ZAP-70  and 
related  Syk  PTKs  (10-12,  35-38).  Increased  levels  of Syk 
were  observed  in  both  the  HTLV-i-transformed  thy- 
mocyte  and peripheral T  cell fines derived from the  ZAP- 
70-deficient  patient  described  in  this  report  (reference  26, 
and Bacon,  K.,  S.  Smith,  T. Jahn,  T.  Kadlecek,  A.  Weiss, 
K.  Weinberg,  and  N.  Taylor,  unpublished  observations). 
Syk appears  to compensate for ZAP-70  only under specific 
cellular  conditions;  TCR-stimulated  calcium  flux was  ob- 
served in the patient's  IL-2-dependent  thymocyte  cell line 
(26),  but not in  the  IL-2-dependent  peripheral  T  cell line 
derived from the same patient  (Fig.  4).  Nevertheless,  upon 
transition  of the patient's  peripheral  T  cell line  to  IL-2 in- 
dependence  with concurrent  activation  of the JAK/STAT 
klnase  pathway,  as  described  previously  (39-41),  Syk  was 
sufficient to mediate a calcium response (Bacon, K., and N. 
Taylor, unpublished observations). Work is in progress to ad- 
dress the relative contributions  of these two PTKs to TCR 
signaling in ZAP-70-reconstituted  thymocytes and T  cells. 
Our  experiments  focused  on  the  role  of  ZAP-70  in 
TCR  signaling, but the phenotypes of ZAP-70-deficient pa- 
tients  and mice indicate  that  ZAP-70  also plays  an impor- 
tant role in T  cell development (1-3,  42).  ZAP-70-deficient 
patients  have  normal  or increased  numbers  of CD4 ÷  cells 
with a paucity of CD8 + cells, whereas mice with a targeted 
deletion of the ZAP-70 gene express neither CD8 nor CD4 
single  positive  T  cells  (42).  Introduction  of ZAP-70  into 
hematopoietic  stem  cells  isolated  from  the  ZAP-70-defi- 
cient mouse may provide insights into the biological effects of 
exogenous ZAP-70  expression.  It will be important to de- 
termine the bases of the differences between ZAP-70--defi- 
cient patients  and mice,  however,  since  gene therapy pro- 
tocols  for  ZAP-70-deficient  SCID  patients  will  have  to 
target a progenitor ofT  lymphocytes that is able to achieve 
correction  of T  cell  ontogeny.  The  present  experiments 
demonstrating  correction  of  signal  transduction  through 
the TCR  in a ZAP-70-deficient  T  cell line lay the founda- 
tion for these further preclinical investigations. 
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